The global Dysmenorrhea Treatment Market is anticipated to be worth US$ 5937.8 million in 2022 and US$ 13179.8 million by 2032. During the projection period of 2022-2032, the market is estimated to grow at an 8.3% CAGR.
Dysmenorrhea is a clinical name for menstrual cramps in which a woman feels significant stomach discomfort or cramps that may extend to her lower legs and back. Most women develop dysmenorrhea throughout adolescence, usually four to five years after their first menstrual cycle.
Prostaglandins are hormones generated in the uterine lining during menstruation. These prostaglandins trigger uterine muscle spasms, which cause pain and limit uterine blood flow and oxygen. A variety of underlying diseases might cause menstrual issues.
Get a PDF Sample with the Latest Market Insights @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1312
The team of analysts at Future Business Insights are focussing on research and market study to produce different Dysmenorrhea Treatment Market forecasts and predictions at both national and international levels. They have considered several leads of information pertaining to the industry like market figures and merger estimations to assess and produce reliable and informative insights on the Dysmenorrhea Treatment Market.
Key Companies Profiled:
- Novartis Pharmaceuticals Corporation,
- Merck, Inc.,
- Bayer Schering Pharma AG,
- Vanita Therapeutics,
- Alvogen,
- Pfizer, Inc.,
- Nua
- Cora
- Roche Laboratories,
- Taj Pharmaceuticals, Ltd.,
- Sanofi,
- Terramedic, Inc.
Have a Conversation with the Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-1312
Key Segments Profiled In The Global Dysmenorrhea Treatment Market
Dysmenorrhea Treatment Market By Diseases:
- Primary Dysmenorrhea
- Secondary Dysmenorrhea
- Endometriosis
- Adenomyosis
- Uterine Myomas
- Endometrial Polyps
- Cervical Stenosis
- Obstructive Malformations Of Genital Tract
Dysmenorrhea Treatment Market By Therapeutic Class:
- Non-Hormonal Medical Treatment
- Non-Steroidal Anti-Inflammatory Drugs (NSAIDS)
- Non-Selective Nsaids
- Cox-2 Inhibitors
- Transdermal Glyceryl Trinitrate
- Over-The-Counter (Otc) Medications
- Hormonal Medicine Treatment
- Combined Oral Contraceptive
- Progestin Regimens
- Levonorgestrel Intrauterine System (LN-IUS)
- Surgical Options
- Laparoscopy
- Hysterectomy
- Presacral Neurectomy
- Laparoscopic Uterosacral Nerve Ablation (LUNA)
- Intrauterine Device (IUD)
To Buy this Report Visit @ https://www.futuremarketinsights.com/checkout/1312
Dysmenorrhea Treatment Market By Region:
- North America
- Latin America
- Eastern Europe
- Western Europe
- APAC
- Japan
- MEA
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs
